Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity
Jeff Bluestone, CEO of Sonoma Biotherapeutics, on…
The Long Run with Luke Timmerman · Timmerman Report
December 1, 20211h 7m
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Jeff Bluestone, CEO of Sonoma Biotherapeutics, on engineered T-reg cell therapies for autoimmunity.